185 related articles for article (PubMed ID: 37056922)
21. Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function.
Helbing T; Wiltgen G; Hornstein A; Brauers EZ; Arnold L; Bauer A; Esser JS; Diehl P; Grundmann S; Fink K; Patterson C; Bode C; Moser M
Inflammation; 2017 Apr; 40(2):442-453. PubMed ID: 27995357
[TBL] [Abstract][Full Text] [Related]
22. Exposing endothelial cells to tumor necrosis factor-α and peripheral blood mononuclear cells damage endothelial integrity via interleukin-1ß by degradation of vascular endothelial-cadherin.
Seynhaeve AL; Rens JA; Schipper D; Eggermont AM; Ten Hagen TL
Surgery; 2014 Mar; 155(3):545-53. PubMed ID: 24439748
[TBL] [Abstract][Full Text] [Related]
23. Interaction of fibrin with VE-cadherin.
Martinez J; Ferber A; Bach TL; Yaen CH
Ann N Y Acad Sci; 2001; 936():386-405. PubMed ID: 11460494
[TBL] [Abstract][Full Text] [Related]
24. VE-cadherin facilitates BMP-induced endothelial cell permeability and signaling.
Benn A; Bredow C; Casanova I; Vukičević S; Knaus P
J Cell Sci; 2016 Jan; 129(1):206-18. PubMed ID: 26598555
[TBL] [Abstract][Full Text] [Related]
25. Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization.
Lei X; Chen M; Huang M; Li X; Shi C; Zhang D; Luo L; Zhang Y; Ma N; Chen H; Liang H; Ye W; Zhang D
Theranostics; 2018; 8(2):384-398. PubMed ID: 29290815
[TBL] [Abstract][Full Text] [Related]
26. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin.
Gavard J; Gutkind JS
Nat Cell Biol; 2006 Nov; 8(11):1223-34. PubMed ID: 17060906
[TBL] [Abstract][Full Text] [Related]
27. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of VE-PTP from VE-cadherin is required for leukocyte extravasation and for VEGF-induced vascular permeability in vivo.
Broermann A; Winderlich M; Block H; Frye M; Rossaint J; Zarbock A; Cagna G; Linnepe R; Schulte D; Nottebaum AF; Vestweber D
J Exp Med; 2011 Nov; 208(12):2393-401. PubMed ID: 22025303
[TBL] [Abstract][Full Text] [Related]
29. Enhanced endothelial barrier function by monoclonal antibody activation of vascular endothelial cadherin.
Park KS; Schecterson L; Gumbiner BM
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1403-H1410. PubMed ID: 33577432
[TBL] [Abstract][Full Text] [Related]
30. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
Friedl J; Turner E; Alexander HR
Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
[TBL] [Abstract][Full Text] [Related]
31. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
32. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
[TBL] [Abstract][Full Text] [Related]
33. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
[TBL] [Abstract][Full Text] [Related]
34. Soluble vascular endothelial-cadherin levels in patients with sepsis treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
Ebihara I; Hirayama K; Nagai M; Koda M; Gunji M; Okubo Y; Katayama T; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2014 Jun; 18(3):272-8. PubMed ID: 24965294
[TBL] [Abstract][Full Text] [Related]
35. Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer.
Le Guelte A; Dwyer J; Gavard J
Biol Cell; 2011 Dec; 103(12):593-605. PubMed ID: 22054419
[TBL] [Abstract][Full Text] [Related]
36. Rab5-mediated VE-cadherin internalization regulates the barrier function of the lung microvascular endothelium.
Yang J; Yao W; Qian G; Wei Z; Wu G; Wang G
Cell Mol Life Sci; 2015 Dec; 72(24):4849-66. PubMed ID: 26112597
[TBL] [Abstract][Full Text] [Related]
37. A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability.
Corada M; Zanetta L; Orsenigo F; Breviario F; Lampugnani MG; Bernasconi S; Liao F; Hicklin DJ; Bohlen P; Dejana E
Blood; 2002 Aug; 100(3):905-11. PubMed ID: 12130501
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.
Menon C; Ghartey A; Canter R; Feldman M; Fraker DL
Ann Surg; 2006 Nov; 244(5):781-91. PubMed ID: 17060772
[TBL] [Abstract][Full Text] [Related]
39. Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.
Wan R; Guo R; Chen C; Jin L; Zhu C; Zhang Q; Xu Y; Li S
J Cell Physiol; 2013 Jun; 228(6):1295-303. PubMed ID: 23168683
[TBL] [Abstract][Full Text] [Related]
40. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
